Piperazine protects the rat heart against sudden cardiac death from barium chloride-induced ventricular fibrillation

American Journal of Therapeutics

Volumn 15, Issue 2, 2008, Pages 119-125

  Ghasi, Samuel ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Arrhythmia; Cardioprotection; Electrocardiogram; Piperazine; Rat

Indexed keywords

BARIUM CHLORIDE; PIPERAZINE CITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; EXTERNAL JUGULAR VEIN; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; NONHUMAN; P WAVE; PRIORITY JOURNAL; QRS COMPLEX; RAT; SINUS RHYTHM; SUDDEN DEATH;

ANIMALS; ANTHELMINTICS; ANTI-ARRHYTHMIA AGENTS; BARIUM COMPOUNDS; CHLORIDES; DEATH, SUDDEN, CARDIAC; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; HEART; PIPERAZINES; RATS; RATS, WISTAR; VENTRICULAR FIBRILLATION;

EID: 41349114457     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3180a5e6b7     Document Type: Article

References (34)

1. Onuaguluchi G, Igbo INA. Comparative antiarrhythmic and local anaesthetic effects of piperazine citrate and lignocaine hydrochloride. Arch Int Pharmacodyn Therap. 1985;274:253-266.
2. Onuaguluchi G. Some aspects of the pharmacology of piperazine citrate and the antiascaris fraction of the ethanolic extract of the bark of ERIN tree (Polyadoa umbellate-Dalziel). West Afr Med J. 1966;15:22-25.
3. Onuaguluchi G. Effect of the antiascaris fraction of the ethanolic extract of the bark of Polyadoa unbellata (ERIN) and of piperazine citrate on mammalian non-vascular smooth muscle. The Pharmacologist. 1981;23:45.
4. Onuaguluchi G. Effect of piperazine citrate and of the antiascaris fraction of the bark of Polyadoa umbellate (ERIN) on mammalian non-vascular smooth muscle. Arch Int Pharmacodyn Therap. 1984;269:263-270.
5. Katzung B. Evaluation of drugs affecting the contractility and the electrical properties of the heart. In: Burger A, ed. Selected Pharmacological Testing Methods. Vol. 3. E. A. Publications; 1968:193-234.
6. Akita M, Kuwahara M, Tsubone H, et al. ECG changes during furosemide-induced hypokalemia in the rat. J Electrocardiol. 1998;31:45-49.
7. Aberra A, Komukai K, Howarth FC, et al. The effect of acidosis on the rat heart. Exp Physiol. 2001;86:27-31.
8. Sgoifo A, De Boer SF, Westenbroek C, et al. Incidence of arrhythmias and heart rate variability in wild-type rats exposed to social stress. Am Physiol Society 1997:H1754-H1760.
9. Watkinson WP, Campen MJ, Costa DL. Cardiac arrhythmia induction after exposure to residual oil fly ash particles in a rodent model of pulmonary hypertension, Toxicol Sci. 1998;41:209-216.
10. Sgoifo A, De Boer SF, Buwalda B, et al. Vulnerability to arrhythmias during social stress in rats with different sympathovagal balance. Am Physiol Society. 1998:H460-H466.
11. Kharidia J, Eddington ND. Effects of desethyloamiodarone on the electrocardiogram in conscious freely moving animals: pharmacokinetic and pharmacodynamic modelling using computer-assisted radio telemetry. Biopharm Drug Disposition. 1996:93-106.
12. Matthew CB, Bastille AM, Gonzalez RR, et al. Heart rate variability and electrocardiogram waveform as predictors of morbidity during hypothermia and rewarming in rats. Canad J Physiol Pharmacol. 2002;80:925-933.
13. Onuaguluchi G, Ghasi S. Electrocardiographic profile of oral piperazine citrate in healthy volunteers. Am J Therap. 2006;13:43-47.
14. Singh KP, Penddse VIK, Bandy DS. Cyproheptadine in ventricular arrhythmias. Indian Heart J. 1975;27:120-128.
15. Onuaguluchi G, Tanz RD, Mccawley E. Electrocardiographic changes induced by amrinone in the isolated perfused Guinea-pig Langendorff heart preparation. Arch Int Pharmacodyn Therap. 1983;264:263-273.
16. 2+ in frog sartorious fibres. J Gen Physiol. 1967;50:1565-1583.
17. + current. Am J Physiol Heart Circ Physiol. 2000;278:H295-H299.
18. th ed. New York: Macmillan; 1975:782-795.
19. Rosa O, Berman LB. The pathophysiology of barium hypokalaemic and cardiovascular effects. J Pharmacol Exp Therap. 1971;177:433-439.
20. Gould DB, Sorrel MR, Luparielo AD. Barium sulphide poisoning: some factors contributing to survival. Arch Intern Med. 1973;1321:891-894.
21. Dreisbach RH. Miscellaneous pesticides. In: Handbook of Poisoning. Lange Medical Publications; 1980.
22. Roden DM. Antiarrhythmic drugs. In: Hardman JG, Limbird LE, Gilman AG, eds. The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw Hill, Medical Publishing Division; 2001:933-970.
23. Curtis MJ, Hearse DJ. Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol. 1989;21:21-40.
24. Yano K, Hirata M, Matsumoto Y, et al. Effects of chronic hypokalaemia on ventricular vulnerability during acute myocardial ischaemia in the dog. Jap Heart J. 1989;30:205-217.
25. +) ATPase from cultured heart cells. Biochem Biophys Acta. 1968;163:415-417.
26. + channel inhibition by antiarrhythmic piperazine. Biochemistry. 2004;14:15577-15583.
27. Habuchi Y, Tanaka H, Furukawa T, et al. Endothelin enhances delayed potassium current via phospholipase C in guinea pig ventricular myocytes. Am J Physiol. 1992;262:H345-H354.
28. + channel blocking and antimuscarinic effects of a novel piperazine derivative INO2628, on the isolated dog atrium. Eur J Pharmacol. 1991;193:217-222.
29. Echt DS, Black DN, Barbey JT, et al. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs: sodium channel block and action potential prolongation. Circulation. 1989;79:1106-1117.
30. Roden DM. Current status of class III antiarrhythmic drug therapy. Am J Cardiol. 1993;72:44B-49B.
31. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation, 1991;84:1831-1851.
32. Singh BN. Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact. Eur Heart J. 1993;14:14-23.
33. Allely MC, Alps BC. Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion. Br J Pharmacol. 1990;99:5-6.
34. Jadronova O, Kuzelova M, Seginko J, et al. The effect of piperazine analogs of aryloxyaminopropanol (IIIq and IIIb) on the occurrence of reperfusion dysrhythmia in an in vivo experiment on rats. Ceska Slov Farm. 1996;45:292-295.